WO2004084856A2 - Nouveau systeme galenique pour le transport d’actif, procede de preparation et utilisation - Google Patents
Nouveau systeme galenique pour le transport d’actif, procede de preparation et utilisation Download PDFInfo
- Publication number
- WO2004084856A2 WO2004084856A2 PCT/FR2004/000729 FR2004000729W WO2004084856A2 WO 2004084856 A2 WO2004084856 A2 WO 2004084856A2 FR 2004000729 W FR2004000729 W FR 2004000729W WO 2004084856 A2 WO2004084856 A2 WO 2004084856A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- wax
- particles
- mixture
- galenic system
- active
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pain & Pain Management (AREA)
- Biophysics (AREA)
- Anesthesiology (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ542590A NZ542590A (en) | 2003-03-24 | 2004-03-24 | New galenic system for transport of an active constituent, preparation process and use |
AU2004224601A AU2004224601A1 (en) | 2003-03-24 | 2004-03-24 | Novel galenical system for active transport, method for preparation and use |
EP04742337.1A EP1605918B1 (fr) | 2003-03-24 | 2004-03-24 | Systeme galenique pour le transport d'actif, procede de preparation et utilisation |
MXPA05010217A MXPA05010217A (es) | 2003-03-24 | 2004-03-24 | Nuevo sistmica galenico par transporte activo, metodo para preparacion y uso. |
US10/550,027 US20070116728A1 (en) | 2003-03-24 | 2004-03-24 | Novel galenical system for active transport, method for preparation and use |
CA2519962A CA2519962C (fr) | 2003-03-24 | 2004-03-24 | Nouveau systeme galenique pour le transport d`actif, procede de preparation et utilisation |
JP2006505750A JP5072355B2 (ja) | 2003-03-24 | 2004-03-24 | 有効成分輸送のための新規なガレヌス製剤系、調製方法及び使用 |
US12/767,248 US8911788B2 (en) | 2003-03-24 | 2010-04-26 | Galenical system for active transport, method for preparation and use |
US14/523,999 US9192679B2 (en) | 2003-03-24 | 2014-10-27 | Galenical system for active transport, method for preparation and use |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0303568A FR2852843B1 (fr) | 2003-03-24 | 2003-03-24 | Systeme galenique permettant le masquage du gout |
FR03/03568 | 2003-03-24 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/550,027 A-371-Of-International US20070116728A1 (en) | 2003-03-24 | 2004-03-24 | Novel galenical system for active transport, method for preparation and use |
US12/767,248 Continuation US8911788B2 (en) | 2003-03-24 | 2010-04-26 | Galenical system for active transport, method for preparation and use |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004084856A2 true WO2004084856A2 (fr) | 2004-10-07 |
WO2004084856A3 WO2004084856A3 (fr) | 2004-11-25 |
Family
ID=32947122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2004/000729 WO2004084856A2 (fr) | 2003-03-24 | 2004-03-24 | Nouveau systeme galenique pour le transport d’actif, procede de preparation et utilisation |
Country Status (10)
Country | Link |
---|---|
US (3) | US20070116728A1 (fr) |
EP (1) | EP1605918B1 (fr) |
JP (1) | JP5072355B2 (fr) |
KR (1) | KR20060012576A (fr) |
AU (1) | AU2004224601A1 (fr) |
CA (1) | CA2519962C (fr) |
FR (1) | FR2852843B1 (fr) |
MX (1) | MXPA05010217A (fr) |
NZ (1) | NZ542590A (fr) |
WO (1) | WO2004084856A2 (fr) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2879930A1 (fr) * | 2004-12-23 | 2006-06-30 | Oralance Pharma Sa | Nouveau systeme galenique pour le transport d'actif, procede de preparation et utilisation |
FR2913884A1 (fr) * | 2007-03-21 | 2008-09-26 | Oralance Pharma Sa | Systeme galenique hydrophobe non ionisable |
FR2935270A1 (fr) * | 2008-08-28 | 2010-03-05 | Oralance Pharma | Composition pharmaceutique de temozolomide pour usage pediatrique |
WO2014135967A1 (fr) | 2013-03-06 | 2014-09-12 | Capsugel Belgium Nv | Particules lipidiques solides de curcumine et procédés de préparation et utilisation |
US8911788B2 (en) | 2003-03-24 | 2014-12-16 | Capsugel France SAS | Galenical system for active transport, method for preparation and use |
WO2015189726A1 (fr) | 2014-06-10 | 2015-12-17 | Capsugel Belgium Nv | Comprimé à désintégration orale contenant des particules lipidiques solides, et procédé de préparation et méthode d'utilisation de celui-ci |
WO2019171009A1 (fr) * | 2018-03-08 | 2019-09-12 | Karim Ioualalen | Formulation gastro-protégée et hydrophobe d'au moins un principe actif et procédé d'obtention |
US11324699B2 (en) | 2014-12-04 | 2022-05-10 | Capsugel Belgium Nv | Lipid multiparticulate formulations |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8613956B2 (en) * | 2008-06-23 | 2013-12-24 | International Flora Technologies, Ltd. | Cosmetic particles that transform from hard to soft particles comprising hydrogenated long-chain triglyceride oils |
JP6305414B2 (ja) * | 2012-10-18 | 2018-04-04 | ディーエスエム アイピー アセッツ ビー.ブイ. | カロテノイドを含むビードレット |
US9744221B2 (en) | 2014-12-23 | 2017-08-29 | Synthetic Biologics, Inc. | Method and compositions for inhibiting or preventing adverse effects of oral antibiotics |
FR3059903B1 (fr) * | 2016-12-08 | 2019-03-22 | Salsarulo Pharma | Medicament oral comprenant un laxatif osmotique incorpore dans une matrice a base de matieres grasses vegetales |
US11452687B2 (en) | 2016-12-08 | 2022-09-27 | Salsarulo Pharma | Oral medicament comprising an osmotic laxative incorporated into a matrix based on plant fats with reduced doses of macrogol |
US10639607B2 (en) | 2017-06-16 | 2020-05-05 | Matralix Pte Ltd | Systems and methods for preparing wax and lipid particles |
CN111328284A (zh) | 2017-08-07 | 2020-06-23 | 芬奇治疗公司 | 用于维持和恢复健康的肠道屏障的组合物和方法 |
US11338020B2 (en) | 2018-01-09 | 2022-05-24 | Synthetic Biologics, Inc. | Alkaline phosphatase agents for treatment of neurodevelopmental disorders |
EP3773686B1 (fr) | 2018-03-20 | 2023-06-07 | Theriva Biologics, Inc. | Agents au phosphatase alcaline pour le traitement de troubles dus à une exposition à des radiations |
FR3079146B1 (fr) * | 2018-03-23 | 2020-04-17 | Karim Ioualalen | Formulation gastroprotectrice de complexes d’enzymes permettant de restaurer la fonction digestive. |
EP4028036A1 (fr) | 2019-09-13 | 2022-07-20 | Finch Therapeutics Holdings LLC | Compositions et méthodes de traitement de trouble du spectre autistique |
CA3158132A1 (fr) | 2019-10-18 | 2021-04-22 | Finch Therapeutics Holdings Llc | Compositions et procedes pour administrer un metabolite bacterien a un sujet |
WO2021097288A1 (fr) | 2019-11-15 | 2021-05-20 | Finch Therapeutics Holdings Llc | Compositions et méthodes de traitement de maladies neurodégénératives |
WO2021142353A1 (fr) | 2020-01-10 | 2021-07-15 | Finch Therapeutics Holdings Llc | Compositions et méthodes pour le traitement de l'hépatite b (vhb) et de l'hépatite d (vhd) |
WO2021142358A1 (fr) | 2020-01-10 | 2021-07-15 | Finch Therapeutics Holdings Llc | Compositions et méthodes pour le traitement de l'encéphalopathie hépatique (eh) |
WO2021142347A1 (fr) | 2020-01-10 | 2021-07-15 | Finch Therapeutics Holdings Llc | Compositions et procédés relatifs à la stéatohépatite non alcoolique (nash) |
US20230201265A1 (en) | 2020-03-31 | 2023-06-29 | Finch Therapeutics Holdings Llc | Compositions comprising non-viable fecal microbiota and methods of use thereof |
WO2022178294A1 (fr) | 2021-02-19 | 2022-08-25 | Finch Therapeutics Holdings Llc | Compositions et méthodes pour fournir des acides biliaires secondaires à un sujet |
CN113308045B (zh) * | 2021-05-28 | 2022-03-22 | 宁波市鑫晟工贸实业有限公司 | 一种抗老化的塑料盒及其制备方法 |
US20230256056A1 (en) * | 2022-02-11 | 2023-08-17 | Insitu Biologics, Inc. | Sustained release cancer therapeutics formulations |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1323161A (en) * | 1970-02-16 | 1973-07-11 | Wyeth John & Brother Ltd | Penicillin composition |
US4132753A (en) * | 1965-02-12 | 1979-01-02 | American Cyanamid Company | Process for preparing oral sustained release granules |
WO1994012157A1 (fr) * | 1992-11-30 | 1994-06-09 | Kv Pharmaceutical Company | Substances pharmaceutiques au gout camoufle |
WO1999013864A2 (fr) * | 1997-09-19 | 1999-03-25 | Shire Laboratories, Inc. | Granule de solution solide |
EP0911038A1 (fr) * | 1997-10-21 | 1999-04-28 | Odette Salsarulo | Composition anhydre à base de lactulose |
WO1999065448A2 (fr) * | 1998-06-17 | 1999-12-23 | Karim Ioulalen | Composition cosmetique ou dermo-pharmaceutique sous forme de perles et procedes pour la preparation |
WO2000076481A1 (fr) * | 1999-06-14 | 2000-12-21 | Cosmo S.P.A. | Compositions pharmaceutiques orales a liberation regulee a base de mesalazine |
WO2000076478A1 (fr) * | 1999-06-14 | 2000-12-21 | Cosmo S.P.A. | Compositions pharmaceutiques administrables par voie orale a liberation controlee et gout masque |
EP1197207A2 (fr) * | 2000-10-10 | 2002-04-17 | American Cyanamid Company | Compositions stabilisées pour l'administration parentérale |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3146167A (en) * | 1961-10-05 | 1964-08-25 | Smith Kline French Lab | Method of preparing sustained release pellets and products thereof |
US4132375A (en) * | 1976-01-21 | 1979-01-02 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Vortex-lift roll-control device |
US4590062A (en) * | 1984-04-16 | 1986-05-20 | Tech Trade Corp. | Dry direct compression compositions for controlled release dosage forms |
JPS63301815A (ja) * | 1987-01-29 | 1988-12-08 | Taisho Pharmaceut Co Ltd | 経口製剤の製造方法 |
JP2700662B2 (ja) * | 1988-06-22 | 1998-01-21 | 大正製薬株式会社 | 被覆製剤 |
JPH02200639A (ja) * | 1989-01-31 | 1990-08-08 | Shinfusou Seiyaku Kk | 脂質被覆細菌製剤 |
IT1229856B (it) | 1989-04-20 | 1991-09-13 | Recordati Chem Pharm | Compresse a rilascio controllato contenenti flavossato. |
US5213810A (en) | 1990-03-30 | 1993-05-25 | American Cyanamid Company | Stable compositions for parenteral administration and method of making same |
ATE134873T1 (de) | 1991-07-23 | 1996-03-15 | American Cyanamid Co | Stabile zusammensetzungen für parenterale verabrechung und ihre verwendung |
DE4131562A1 (de) | 1991-09-18 | 1993-03-25 | Medac Klinische Spezialpraep | Arzneistofftraeger aus festen lipidteilchen-feste lipidnanosphaeren (sln) |
CA2091152C (fr) | 1993-03-05 | 2005-05-03 | Kirsten Westesen | Particules lipidiques solides, particules d'agents bioactifs, et methode de preparation et d'utilisation |
DE4308282C2 (de) | 1993-03-16 | 1994-12-22 | Beiersdorf Ag | Vorzugsweise in Form von Mikrosphärulen vorliegende galenische Matrices |
WO1998050019A1 (fr) | 1997-05-09 | 1998-11-12 | Sage Pharmaceuticals, Inc. | Formes posologiques pharmaceutiques orales stables |
BR0010354A (pt) | 1999-05-07 | 2002-03-05 | Pharmasol Gmbh | Partìculas de lipìdeo à base em misturas de lipìdeos lìquidos e sólidos e método para a sua produção |
JP3597823B2 (ja) | 2002-02-07 | 2004-12-08 | 沢井製薬株式会社 | 固形製剤 |
FR2852843B1 (fr) | 2003-03-24 | 2008-05-23 | Karim Ioualalen | Systeme galenique permettant le masquage du gout |
-
2003
- 2003-03-24 FR FR0303568A patent/FR2852843B1/fr not_active Expired - Lifetime
-
2004
- 2004-03-24 MX MXPA05010217A patent/MXPA05010217A/es active IP Right Grant
- 2004-03-24 EP EP04742337.1A patent/EP1605918B1/fr not_active Expired - Lifetime
- 2004-03-24 NZ NZ542590A patent/NZ542590A/en unknown
- 2004-03-24 WO PCT/FR2004/000729 patent/WO2004084856A2/fr active Application Filing
- 2004-03-24 AU AU2004224601A patent/AU2004224601A1/en not_active Abandoned
- 2004-03-24 US US10/550,027 patent/US20070116728A1/en not_active Abandoned
- 2004-03-24 KR KR1020057017992A patent/KR20060012576A/ko not_active Application Discontinuation
- 2004-03-24 JP JP2006505750A patent/JP5072355B2/ja not_active Expired - Lifetime
- 2004-03-24 CA CA2519962A patent/CA2519962C/fr not_active Expired - Fee Related
-
2010
- 2010-04-26 US US12/767,248 patent/US8911788B2/en not_active Expired - Lifetime
-
2014
- 2014-10-27 US US14/523,999 patent/US9192679B2/en not_active Expired - Fee Related
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4132753A (en) * | 1965-02-12 | 1979-01-02 | American Cyanamid Company | Process for preparing oral sustained release granules |
GB1323161A (en) * | 1970-02-16 | 1973-07-11 | Wyeth John & Brother Ltd | Penicillin composition |
WO1994012157A1 (fr) * | 1992-11-30 | 1994-06-09 | Kv Pharmaceutical Company | Substances pharmaceutiques au gout camoufle |
WO1999013864A2 (fr) * | 1997-09-19 | 1999-03-25 | Shire Laboratories, Inc. | Granule de solution solide |
EP0911038A1 (fr) * | 1997-10-21 | 1999-04-28 | Odette Salsarulo | Composition anhydre à base de lactulose |
WO1999065448A2 (fr) * | 1998-06-17 | 1999-12-23 | Karim Ioulalen | Composition cosmetique ou dermo-pharmaceutique sous forme de perles et procedes pour la preparation |
WO2000076481A1 (fr) * | 1999-06-14 | 2000-12-21 | Cosmo S.P.A. | Compositions pharmaceutiques orales a liberation regulee a base de mesalazine |
WO2000076478A1 (fr) * | 1999-06-14 | 2000-12-21 | Cosmo S.P.A. | Compositions pharmaceutiques administrables par voie orale a liberation controlee et gout masque |
EP1197207A2 (fr) * | 2000-10-10 | 2002-04-17 | American Cyanamid Company | Compositions stabilisées pour l'administration parentérale |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8911788B2 (en) | 2003-03-24 | 2014-12-16 | Capsugel France SAS | Galenical system for active transport, method for preparation and use |
WO2006070117A1 (fr) * | 2004-12-23 | 2006-07-06 | Oralance Pharma | Nouveau systeme galenique pour le transport d'actif, procede de preparation et utilisation |
FR2879930A1 (fr) * | 2004-12-23 | 2006-06-30 | Oralance Pharma Sa | Nouveau systeme galenique pour le transport d'actif, procede de preparation et utilisation |
FR2913884A1 (fr) * | 2007-03-21 | 2008-09-26 | Oralance Pharma Sa | Systeme galenique hydrophobe non ionisable |
WO2008125423A1 (fr) * | 2007-03-21 | 2008-10-23 | Oralance Pharma | Système galénique hydrophobe non ionisable |
US20100086595A1 (en) * | 2007-03-21 | 2010-04-08 | Oralance Pharma Faculte De Medecine Cochin | Non-ionizable hydrophobic galenical system |
FR2935270A1 (fr) * | 2008-08-28 | 2010-03-05 | Oralance Pharma | Composition pharmaceutique de temozolomide pour usage pediatrique |
WO2014135967A1 (fr) | 2013-03-06 | 2014-09-12 | Capsugel Belgium Nv | Particules lipidiques solides de curcumine et procédés de préparation et utilisation |
US10166187B2 (en) | 2013-03-06 | 2019-01-01 | Capsugel Belgium Nv | Curcumin solid lipid particles and methods for their preparation and use |
WO2015189726A1 (fr) | 2014-06-10 | 2015-12-17 | Capsugel Belgium Nv | Comprimé à désintégration orale contenant des particules lipidiques solides, et procédé de préparation et méthode d'utilisation de celui-ci |
EP3766480A1 (fr) | 2014-06-10 | 2021-01-20 | Capsugel Belgium NV | Comprimé à désintégration orale contenant des particules lipidiques solides, et son procédé de préparation et d'utilisation |
US11324699B2 (en) | 2014-12-04 | 2022-05-10 | Capsugel Belgium Nv | Lipid multiparticulate formulations |
WO2019171009A1 (fr) * | 2018-03-08 | 2019-09-12 | Karim Ioualalen | Formulation gastro-protégée et hydrophobe d'au moins un principe actif et procédé d'obtention |
FR3078630A1 (fr) * | 2018-03-08 | 2019-09-13 | Karim Ioualalen | Mode de formulation sous forme de solide divise hydrophobe |
Also Published As
Publication number | Publication date |
---|---|
JP5072355B2 (ja) | 2012-11-14 |
FR2852843A1 (fr) | 2004-10-01 |
US20100221298A1 (en) | 2010-09-02 |
US9192679B2 (en) | 2015-11-24 |
AU2004224601A1 (en) | 2004-10-07 |
US20070116728A1 (en) | 2007-05-24 |
CA2519962C (fr) | 2015-03-10 |
US8911788B2 (en) | 2014-12-16 |
NZ542590A (en) | 2009-02-28 |
FR2852843B1 (fr) | 2008-05-23 |
JP2006521334A (ja) | 2006-09-21 |
KR20060012576A (ko) | 2006-02-08 |
EP1605918A2 (fr) | 2005-12-21 |
MXPA05010217A (es) | 2006-03-28 |
EP1605918B1 (fr) | 2016-09-28 |
WO2004084856A3 (fr) | 2004-11-25 |
CA2519962A1 (fr) | 2004-10-07 |
US20150044297A1 (en) | 2015-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1605918B1 (fr) | Systeme galenique pour le transport d'actif, procede de preparation et utilisation | |
EP1827382B1 (fr) | Nouveau systeme galenique pour le transport d'actif, procede de preparation et utilisation | |
CA2341580C (fr) | Composition cosmetique ou dermo-pharmaceutique sous forme de perles et procedes pour la preparation | |
EP3076944A1 (fr) | Microcapsules lipidiques comprenant de preference un actif lipophile et composition les contenant, leur procede de preparation et leur utilisation en dermatologie et en cosmetique | |
CA2231342C (fr) | Composition pharmaceutique pour administration par voie orale | |
EP3033110A1 (fr) | Nouveau systeme solide instantane auto-emulsionnant a base de cyclodextrines et d'huile (s) pour l'administration orale | |
CA3093235A1 (fr) | Formulation gastro-protegee et hydrophobe d'au moins un principe actif et procede d'obtention | |
FR2803202A1 (fr) | Compositions pharmaceutiques destinees a une adminstration par voie orale | |
FR2663538A1 (fr) | Procede de preparation de microspheres de corps gras chargees ou non chargees en une substance active. | |
FR3006894A1 (fr) | Microparticules avec des cyclodextrines a double-niveaux d’encapsulation | |
EP2139454A1 (fr) | Système galénique hydrophobe non ionisable | |
WO2017162822A1 (fr) | Compositions adhérant aux muqueuses et leurs utilisations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2519962 Country of ref document: CA Ref document number: 171043 Country of ref document: IL Ref document number: 542590 Country of ref document: NZ Ref document number: 2006505750 Country of ref document: JP |
|
REEP | Request for entry into the european phase |
Ref document number: 2004742337 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2005/010217 Country of ref document: MX Ref document number: 2004742337 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020057017992 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004224601 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2004224601 Country of ref document: AU Date of ref document: 20040324 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2004224601 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2004742337 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020057017992 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007116728 Country of ref document: US Ref document number: 10550027 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 10550027 Country of ref document: US |